Non-Small Cell Lung Cancer, Version 4.2024

被引：108

作者：

Riely, Gregory J. ^{[1
]}

Wood, Douglas E. ^{[2
]}

Ettinger, David S. ^{[3
]}

Aisner, Dara L. ^{[4
]}

Akerley, Wallace ^{[5
]}

Bauman, Jessica R. ^{[6
]}

Bharat, Ankit ^{[7
]}

Bruno, Debora S. ^{[8
]}

Chang, Joe Y. ^{[9
]}

Chirieac, Lucian R. ^{[10
]}

Decamp, Malcolm ^{[1
,11
]}

Desai, Aakash P. ^{[1
,2
,12
]}

Dilling, Thomas J. ^{[1
,3
,13
]}

Dowell, Jonathan ^{[1
,4
,14
]}

Durm, Gregory A. ^{[1
,5
,15
]}

Gettinger, Scott ^{[1
,6
,16
]}

Grotz, Travis E. ^{[1
,7
,17
]}

Gubens, Matthew A. ^{[1
,8
,18
]}

Juloori, Aditya ^{[1
,9
,19
]}

Lackner, Rudy P. ^{[2
,20
]}

Lanuti, Michael ^{[1
,2
,21
]}

Lin, Jules ^{[2
,22
]}

Loo, Billy W., Jr. ^{[2
,3
,23
]}

Lovly, Christine M. ^{[2
,4
,24
]}

Maldonado, Fabien ^{[2
,4
,24
]}

Massarelli, Erminia ^{[2
,5
,25
]}

Morgensztern, Daniel ^{[2
,6
,26
]}

Mullikin, Trey C. ^{[2
,7
,27
]}

Ng, Thomas ^{[2
,8
,28
]}

Owen, Dawn ^{[1
,7
,17
]}

Owen, Dwight H. ^{[2
,9
,29
]}

Patel, Sandip P. ^{[3
,30
]}

Patil, Tejas ^{[4
]}

Polanco, Patricio M. ^{[1
,4
,14
]}

Riess, Jonathan ^{[1
,3
,31
]}

Shapiro, Theresa A. ^{[3
]}

Singh, Aditi P. ^{[2
,3
,32
]}

Stevenson, James ^{[8
]}

Tam, Alda ^{[9
]}

Tanvetyanon, Tawee ^{[1
,3
,13
]}

Yanagawa, Jane ^{[3
,33
]}

Yang, Stephen C. ^{[3
]}

Yau, Edwin ^{[3
,4
,34
]}

Gregory, Kristina M. ^{[35
]}

Hang, Lisa ^{[3
,5
,35
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA

[2] Fred Hutchinson Canc Ctr, Sunnyside, WA USA

[3] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Mcadoo, PA USA

[4] Univ Colorado, Ctr Canc, Denver, CO 80202 USA

[5] Univ Utah, Huntsman Canc Inst, Biol, Salt Lake City, UT USA

[6] Fox Chase Canc Ctr, Oreland, PA USA

[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[8] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[9] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[10] Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA

[11] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[12] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[13] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[14] UT Southwestern, Simmons Comprehens Canc Ctr, Dallas, TX USA

[15] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN USA

[16] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[17] Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA

[18] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[19] UChicago Med Comprehens Canc Ctr, Maywood, IL USA

[20] Fred & Pamela Buffett Canc Ctr, Clin Infus Ctr, Omaha, NE 68105 USA

[21] Mass Gen Canc Ctr, Waltham, MA USA

[22] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[23] Stanford Canc Inst, Stanford, CA USA

[24] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Med Ctr, Vanderbilt, TN 37232 USA

[25] City Hope Natl Med Ctr, Monrovia, CA USA

[26] Washington Univ Sch Med, Barnes Jewish Hosp, Siteman Canc Ctr, Washington, DC USA

[27] Duke Univ, Duke Canc Inst, Durham, NC USA

[28] Univ Tennessee, Hlth Sci Ctr, Bartlett, TN USA

[29] Ohio State Univ, Solove Res Inst, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA

[30] UC San Diego Moores Canc Ctr, San Diego, CA USA

[31] Uc Davis Comprehens Canc Ctr, Davis, AL USA

[32] Univ Penn, Abramson Canc Ctr, Ctr CLL, Philadelphia, PA USA

[33] UCLA Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[34] Roswell Pk Comprehens Canc Ctr, Biostat, Buffalo, NY USA

[35] Natl Comprehens Canc Network, Rockledge, PA 19111 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2024年 / 22卷 / 04期

关键词：

GROWTH-FACTOR-RECEPTOR; UNCOMMON EGFR MUTATIONS; TYROSINE-KINASE INHIBITOR; EXON; 20; INSERTION; DABRAFENIB PLUS TRAMETINIB; POST-HOC ANALYSIS; OPEN-LABEL; CLINICAL ACTIVITY; NEVER SMOKERS; ACQUIRED-RESISTANCE;

D O I：

10.6004/jnccn.2204.0023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance for relapse, and subsequent treatment. The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data. This selection from the NCCN Guidelines for NSCLC focuses on treatment recommendations for advanced or metastatic NSCLC with actionable molecular biomarkers.

引用

页码：249 / 274

页数：26

共 50 条

[21] Novel therapeutic targets in non-small cell lung cancer
Alamgeer, Muhammad
Ganju, Vinod
Watkins, D. Neil
CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (03) : 394 - 401
[22] RAF and MEK Inhibitors in Non-Small Cell Lung Cancer
Adamopoulos, Christos
Papavassiliou, Kostas A.
Poulikakos, Poulikos I.
Papavassiliou, Athanasios G.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
[23] Therapeutic options for oligoprogressive non-small cell lung cancer
Gustin, P.
Botticella, A.
Tselikas, L.
Mercier, O.
Le Pechoux, C.
Levy, A.
REVUE DES MALADIES RESPIRATOIRES, 2019, 36 (04) : 519 - 526
[24] Precision Management of Advanced Non-Small Cell Lung Cancer
Yang, Ching-Yao
Yang, James Chih-Hsin
Yang, Pan-Chyr
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020, 2020, 71 : 117 - 136
[25] Gefitinib: an "orphan" drug for non-small cell lung cancer
Ziogas, Dimitrios C.
Liontos, Michalis
Kyriazoglou, Anastasios
Tsironis, Georgios
Bamias, Aristotelis
Dimopoulos, Meletios-Athanasios
EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (11): : 899 - 906
[26] Targeted therapies in non-small cell lung cancer in 2014
Leduc, C.
Besse, B.
REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (02) : 182 - 192
[27] MET alterations in advanced non-small cell lung cancer
Chagas, Gabriel Cavalcante Lima
Rangel, Amanda Ribeiro
El Osta, Badi
CURRENT PROBLEMS IN CANCER, 2024, 49
[28] Updates in the molecular pathology of non-small cell lung cancer
Paver, Elizabeth
O'Toole, Sandra
Cheng, Xin Min
Mahar, Annabelle
Cooper, Wendy A.
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2021, 38 (05) : 54 - 61
[29] Novel EGFR Inhibitors in Non-small Cell Lung Cancer: Current Status of Afatinib
Liao, Bin-Chi
Lin, Chia-Chi
Yang, James Chih-Hsin
CURRENT ONCOLOGY REPORTS, 2017, 19 (01)
[30] AFATINIB FOR THE TREATMENT OF PATIENTS WITH EGFR-POSITIVE NON-SMALL CELL LUNG CANCER
Bowles, D. W.
Weickhardt, A.
Jimeno, A.
DRUGS OF TODAY, 2013, 49 (09) : 523 - 535

← 1 2 3 4 5 →